Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biochemically Recurrent Prostate Carcinoma”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)Study completedNCT04019964
What this trial is testing

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Testing effectiveness (Phase 2)Study completedNCT00080899
What this trial is testing

Fenretinide in Treating Patients With Biochemically Recurrent Hormone-Naïve Prostate Cancer

Who this might be right for
Adenocarcinoma of the ProstateRecurrent Prostate Cancer
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Looking for participantsNCT07365423
What this trial is testing

Terbinafine for Biochemically Recurrent Prostate Cancer (TerbinaPro)

Who this might be right for
Recurrent Prostate Cancer
Swiss Cancer Institute 42
Testing effectiveness (Phase 2)Looking for participantsNCT07073794
What this trial is testing

Evaluating In Home Cancer Therapy Versus In Clinic Cancer Therapy in Black Men With Locally Advanced, Biochemically Recurrent and Metastatic Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocally Advanced Prostate CarcinomaMetastatic Prostate Carcinoma+2 more
Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT01787331
What this trial is testing

Itraconazole in Treating Patients With Biochemically Relapsed Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRecurrent Prostate CarcinomaStage I Prostate Adenocarcinoma AJCC v7+2 more
University of California, San Francisco 21
Large-scale testing (Phase 3)Looking for participantsNCT06205316
What this trial is testing

SBRT Versus Hypofractionated Radiotherapy for Biochemically Recurrent or Oligometastatic Prostate Adenocarcinoma

Who this might be right for
Biochemically Recurrent Prostate CarcinomaOligometastatic Prostate CarcinomaRecurrent Prostate Adenocarcinoma+4 more
Mayo Clinic 118
Testing effectiveness (Phase 2)Study completedNCT05526248
What this trial is testing

A Study Called ARAMON to Learn to What Extent Does Study Treatment With Darolutamide Affects Testosterone Levels in Men With Prostate Cancer That Had Not Been Treated With Hormonal Therapy Compared to Treatment With Enzalutamide

Who this might be right for
Biochemically Recurrent Prostate Cancer
Bayer 28
Early research (Phase 1)Ended earlyNCT00313534
What this trial is testing

Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate Cancer

Who this might be right for
Prostate Cancer
University of California, San Francisco 15
Not applicableEnded earlyNCT05437679
What this trial is testing

Characterization of Circulating Tumor Cells (CTCs) in High Risk and Early Metastatic Prostate Cancer Patients Using Parsortix® System

Who this might be right for
High Risk Prostate CarcinomaBiochemically Recurrent Prostate CarcinomaCastration-resistant Prostate Cancer+1 more
Angle plc 9
Testing effectiveness (Phase 2)Looking for participantsNCT06220188
What this trial is testing

PSMA-RLT in Biochemically Recurrent PCa

Who this might be right for
Prostate Cancer Recurrent
Medical University of Vienna 20
Testing effectiveness (Phase 2)Looking for participantsNCT05946824
What this trial is testing

This Study is Evaluating a New Radiation Treatment Technique for Patients Who Have Had Prostate Cancer, Undergone Surgery for Cancer, and Then Have Evidence That Their Prostate Cancer Has Returned.

Who this might be right for
Recurrent Prostate Cancer After Surgery
University of Rochester 80
Testing effectiveness (Phase 2)Looking for participantsNCT04700332
What this trial is testing

PyL in Patients With High Risk and Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
Hoag Memorial Hospital Presbyterian 184
Early research (Phase 1)Active Not RecruitingNCT05077098
What this trial is testing

Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer

Who this might be right for
Recurrent Prostate Cancer
Mark Stein 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT05320406
What this trial is testing

RElugolix VErsus LeUprolide Cardiac Trial

Who this might be right for
Biochemically Recurrent Prostate CarcinomaLocalized Prostate CarcinomaStage I Prostate Cancer AJCC v8+8 more
Emory University 94
Testing effectiveness (Phase 2)Temporarily pausedNCT04519879
What this trial is testing

White Button Mushroom Sup for the Reduction of PSA in Pts With Biochemically Rec or Therapy Naive Fav Risk Prostate CA

Who this might be right for
Prostate AdenocarcinomaPSA FailurePSA Progression+7 more
City of Hope Medical Center 133
Testing effectiveness (Phase 2)Study completedNCT02649439
What this trial is testing

Prostvac in Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 97
Testing effectiveness (Phase 2)Active Not RecruitingNCT04777071
What this trial is testing

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Who this might be right for
Biochemically Recurrent Prostate CarcinomaMetastatic Castration-Resistant Prostate CarcinomaProstate Adenocarcinoma+3 more
University of Washington 141
Testing effectiveness (Phase 2)Ended earlyNCT04336943
What this trial is testing

Durvalumab and Olaparib for the Treatment of Prostate Cancer in Men Predicted to Have a High Neoantigen Load

Who this might be right for
Biochemically Recurrent Prostate CarcinomaProstate Adenocarcinoma
University of Washington 6
Early research (Phase 1)Study completedNCT04428203
What this trial is testing

Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer RecurrentProstate CancerProstate Adenocarcinoma
Zin W Myint 21
Large-scale testing (Phase 3)Study completedNCT00779402
What this trial is testing

PROvenge Treatment and Early Cancer Treatment

Who this might be right for
Prostate Cancer
Dendreon 176
Load More Results